Ziprasidone versus olanzapine in schizophrenia: Six-month continuation study

被引：1
|
作者：
Simpson, GM [1 ]
Weiden, P [1 ]
Pigott, T [1 ]
Romano, SJ [1 ]
Siu, C [1 ]
机构：
[1] Univ So Calif, LAC & USC Med Ctr, Los Angeles, CA USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80225-6
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [31] Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: A systematic review
    Matza, LS
    Baker, TM
    Revicki, DA
    CNS DRUGS, 2005, 19 (06) : 499 - 515
  • [32] Pharmacogenetics of adverse events in schizophrenia treatment: Comparison study of ziprasidone, olanzapine and perazine
    Tybura, Piotr
    Trzesniowska-Drukala, Beata
    Bienkowski, Przemyslaw
    Beszlej, Aleksander
    Frydecka, Dorota
    Mierzejewski, Pawel
    Samochowiec, Agnieszka
    Grzywacz, Anna
    Samochowiec, Jerzy
    PSYCHIATRY RESEARCH, 2014, 219 (02) : 261 - 267
  • [33] Patient compliance and efficacy of quetiapine treatment in schizophrenia: results of six-month follow-up study
    Alptekin, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S406 - S407
  • [34] PHARMACOGENETIC STUDIES OF OLANZAPINE, PERAZINE AND ZIPRASIDONE IN PARANOID SCHIZOPHRENIA
    Samochowiec, J.
    Tybura, P.
    Frydecka, D.
    Beszlej, A.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [35] Pharmacogenetics of Adverse Events in Schizophrenia Treatment: Comparison Study of Ziprasidone, Olanzapine and Perazine
    Tybura, P.
    Trzesniowska-Drukala, B.
    Samochowiec, J.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [36] Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
    Ou, Jian-Jun
    Xu, Yi
    Chen, Hong-Hui
    Fan, Xiaoduo
    Gao, Keming
    Wang, Juan
    Guo, Xiao-Feng
    Wu, Ren-Rong
    Zhao, Jing-Ping
    PSYCHOPHARMACOLOGY, 2013, 225 (03) : 627 - 635
  • [37] Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
    Jian-Jun Ou
    Yi Xu
    Hong-Hui Chen
    Xiaoduo Fan
    Keming Gao
    Juan Wang
    Xiao-Feng Guo
    Ren-Rong Wu
    Jing-Ping Zhao
    Psychopharmacology, 2013, 225 : 627 - 635
  • [38] Prospective Randomized Trial of Six-Month versus Nine-Month Therapy for Intestinal Tuberculosis
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Yang, Dong-Hoon
    Kim, Kyung Jo
    Yoon, Soon Man
    Choe, Jae Won
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Kim, Jin-Ho
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4167 - 4171
  • [39] IS COGNITIVE IMPROVEMENT ASSOCIATED WITH SWITCHING TO A NEW ATYPICAL ANTIPSYCHOTIC SUSTAINED OVER TIME? A SIX-MONTH EXTENSION STUDY OF PATIENTS SWITCHED TO ZIPRASIDONE
    Harvey, Philip
    Bowie, Christopher
    Loebel, Antony
    CLINICAL NEUROPSYCHIATRY, 2005, 2 (02): : 110 - 115
  • [40] Cognitive improvement and neuropsychological normalization with ziprasidone or olanzapine: Results of a 6-month study
    Harvey, PD
    Bowie, CR
    Loebel, A
    Warrington, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S294 - S294
12345